A5036267290- Dementia and Cognitive Impairment Research
- Health Systems, Economic Evaluations, Quality of Life
- Mental Health and Patient Involvement
- Healthcare Systems and Technology
- Cognitive Abilities and Testing
- Cognitive Functions and Memory
- Mental Health and Psychiatry
- Frailty in Older Adults
- Neuroinflammation and Neurodegeneration Mechanisms
- Biological Research and Disease Studies
- Palliative Care and End-of-Life Issues
- Artificial Intelligence in Healthcare
- Alzheimer's disease research and treatments
- Technology Use by Older Adults
- Aging and Gerontology Research
- Blood Pressure and Hypertension Studies
Alzheimer Europe
2018-2024
University of Vechta
2018
ROADMAP is a public-private advisory partnership to evaluate the usability of multiple data sources, including real-world evidence, in decision-making process for new treatments Alzheimer's disease, and advance key concepts disease pharmacoeconomic modeling.ROADMAP identified patient outcomes stakeholders
Computerized cognitive training (CCT) can improve cognition in older adults. However, specific programs for this target group have rarely been developed, and predictors of success are largely unclear. In a randomized controlled pilot trial, we examined effects six-week CCT, tailored to the profile healthy adults (EG, n = 21) as compared nonspecific CCT (CG, 18) matched frequency intensity. No interaction between Group Time were found. within-group analysis showed significant gains verbal...
Computerized cognitive training (CCT) can improve cognition in older adults. However, specific programs for this target group have rarely been developed, and predictors of success are largely unclear. In a randomized controlled pilot trial, we examined effects six-week CCT, tailored to the profile healthy adults (EG, n = 21) as compared nonspecific CCT (CG, 18) matched frequency intensity. No interaction between Group Time were found. within-group analysis showed significant gains verbal...
Abstract Background Sleep‐wake alterations are common symptoms in Alzheimer’s Disease (AD) associated with faster cognitive decline. Noradrenaline dysfunction and neuroinflammation have been proposed as potential driving mechanisms. The ADIS project aims to study the relationship between sleep‐wake patterns, immune signatures (peripheral blood cytotoxic lymphocytes), noradrenergic markers across AD spectrum. Method recruit a total of 75 participants from Hospital Clínic de Barcelona,...